Stocks
Novo Nordisk (NVO) EBITDA margin US GAAP (year values) |
|||||||||
| 2021 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 46.4% | 48.0% | 43.4% | 46.4% | 48.6% | 50.5% | ||
| Changes by years, y/y, % | -1pp | +2pp | -5pp | +3pp | +2pp | +1.2% | |||
Novo Nordisk. EBITDA margin, %
Novo Nordisk. EBITDA margin, changes, pp
Novo Nordisk (NVO) EBITDA margin US GAAP (quarter values) |
||||||||
| 2025Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA margin, % | ? | 49.2% | 55.8% | 43.3% | 54.1% | 50.5% | ||
| Changes by years, y/y, % | -3pp | +4pp | +22pp | +2pp | ||||
| Changes by quarters, q/q, % | -52pp | +7pp | -12pp | +11pp | ||||
